Nanoparticle Technology Reprograms Immune Cells to Fight Solid Tumors
The same technology used to deliver mRNA in COVID-19 vaccines is being used to target a type of immune cell that can help tumors evade the body's defenses.
The same technology used to deliver mRNA in COVID-19 vaccines is being used to target a type of immune cell that can help tumors evade the body's defenses.
A study of more than 14,000 lung cancer patients suggests age influences tumor biology and the availability of targeted therapy options.
Three research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.
Phase 3 trial results show ralinepag significantly reduced the risk of worsening symptoms and improved exercise capacity in pulmonary arterial hypertension patients.
A study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
The minimally invasive surgical approach may allow high-risk or frail patients to become candidates for lung transplantation.
Risk-based models may improve screening efficiency compared to current guidelines, but accuracy issues remain for specific racial and ethnic populations.